{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:13:35Z","timestamp":1785791615454,"version":"3.56.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammation and nutritional status play critical roles in tumor initiation and progression. Advanced Lung Cancer Inflammation Index (ALI) has gained widespread attention as a novel biomarker for cancer prognosis evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study analyzed 163 advanced breast cancer patients with distant metastasis (Guangxi Medical University Cancer Hospital, 2016-2023). Patients were stratified into high-ALI (n=64) and low-ALI (n=99) groups via K-means clustering. Kaplan-Meier survival curves with log-rank testing were used to assess survival differences, while Cox proportional hazards models were employed to evaluate the independent prognostic value of ALI. The predictive performance of ALI was assessed using time-dependent ROC curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High ALI correlated with superior overall survival (log-rank p=0.0024) [HR=2.493 (95%CI 1.350-4.606) p = 0.004]. Multivariate analysis confirmed ALI as an independent prognostic factor (HR=0.39, 95% CI 0.16-0.95, p=0.037). ALI demonstrated stable predictive accuracy with 3-year AUC=0.645 and 5-year AUC=0.650 (C-index=0.65). Subgroup analyses confirmed prognostic consistency across clinical characteristics (p-interaction&amp;gt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ALI is an independent prognostic factor for advanced breast cancer patients with good predictive ability. It provides an important supplementary prognostic marker for clinical practice and can help optimize personalized treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1598069","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:37:56Z","timestamp":1749015476000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index"],"prefix":"10.3389","volume":"15","author":[{"given":"Chunfeng","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"B1","unstructured":"Global Cancer Observatory\n          \n          \n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2020.0523","article-title":"Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030","volume":"18","author":"Lei","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer","volume":"6","author":"Ko","year":"2020","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.249005","article-title":"Screening breast MRI effectively detects early-stage breast cancer in high-risk patients without prior history of breast cancer","volume":"6","author":"Fields","year":"2024","journal-title":"Radiology: Imaging Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10220","article-title":"Beyond randomized controlled trials","volume":"94","author":"Kopans","year":"2002","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds232","article-title":"Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Cardoso","year":"2012","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: an up-to-date review and future perspectives","volume":"42","author":"Hong","year":"2022","journal-title":"Cancer Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7132","article-title":"Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC","volume":"7","author":"Wang","year":"2019","journal-title":"PeerJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865643","article-title":"The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i6.97697","article-title":"Prognostic roles of the prognostic nutritional index in patients with resectable and advanced biliary tract cancers","volume":"31","author":"Zeng","year":"2025","journal-title":"World J Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.08.020","article-title":"Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria","volume":"42","author":"Xie","year":"2023","journal-title":"Clin Nutr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2024.05.039","article-title":"Performance of anthropometry-based and bio-electrical impedance-based muscle-mass indicators in the Global Leadership Initiative on Malnutrition criteria for predicting prognosis in patients with cancer","volume":"43","author":"Xie","year":"2024","journal-title":"Clin Nutr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2281","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals","volume":"8","author":"Guo","year":"2019","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06726-7","article-title":"Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer","volume":"307","author":"von Au","year":"2022","journal-title":"Arch Gynecology Obstetrics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23966","article-title":"High neutrophil-to-lymphocyte ratio as an early sign of cardiotoxicity in breast cancer patients treated with anthracycline","volume":"46","author":"Baruch","year":"2023","journal-title":"Clin Cardiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040958","article-title":"Neutrophil to lymphocyte ratio as prognostic and predictive factor in breast cancer patients: A systematic review","volume":"12","author":"Corbeau","year":"2020","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0794-1","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis","volume":"19","author":"Ethier","year":"2017","journal-title":"Breast Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2004.06.006","article-title":"Inflammation as a tumor promoter in cancer induction","volume":"14","author":"Philip","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0271-7","article-title":"Inflammatory and microenvironmental factors involved in breast cancer progression","volume":"36","author":"Ham","year":"2013","journal-title":"Arch Pharmacal Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02713-5","article-title":"The effect of albumin and hemoglobin levels on the prognosis of early-stage cervical cancer: a prospective, single-center\u2013based cohort study","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Women's Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.08.001","article-title":"Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis","volume":"40","author":"Zhou","year":"2022","journal-title":"Urologic Oncology: Semin Original Investigations"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2192047","article-title":"Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence","volume":"55","author":"Zhang","year":"2023","journal-title":"Ann Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.997314","article-title":"Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-023-02410-1","article-title":"The predictive value of advanced lung cancer inflammation index for short-term outcomes and prognosis of colorectal cancer patients who underwent radical surgery","volume":"28","author":"Zhang","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21037\/jgo-22-657","article-title":"Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection","volume":"14","author":"Chen","year":"2023","journal-title":"J Gastrointestinal Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13032","article-title":"The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer","volume":"13","author":"Song","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00638-2","article-title":"Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation","volume":"10","author":"Chauhan","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103276","article-title":"Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasis","volume":"75","author":"Biondini","year":"2024","journal-title":"Redox Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"N\u00f8st","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205052","article-title":"Characterization of age-associated, neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammatory index (SII) as biomarkers of inflammation in geriatric patients with cancer treated with immune checkpoint inhibitors: impact on efficacy and survival","volume":"15","author":"Choucair","year":"2023","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14379-4","article-title":"Predictive value of neutrophil-to-lymphocyte ratio for distant metastasis in gastric cancer patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000000650","article-title":"The predictive role of hematologic markers in resectable nsclc patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study","author":"Liu","year":"2023","journal-title":"Int J Surgery"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.05.005","article-title":"Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies","volume":"58","author":"Mei","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.773078","article-title":"Preoperative systemic inflammatory biomarkers are independent predictors of disease recurrence in ER+ HER2- early breast cancer","volume":"11","author":"Truffi","year":"2021","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143061","article-title":"The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to-monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients","volume":"10","author":"Lafrenie","year":"2015","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103332","article-title":"Relationship between nutritional status and clinical outcome in patients treated for lung cancer","volume":"13","author":"Pola\u0144ski","year":"2021","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23541","article-title":"The role of nutrition-based index in predicting survival of breast cancer patients: A systematic review and meta-analysis","volume":"10","author":"Prasetiyo","year":"2024","journal-title":"Heliyon"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.67.9712","article-title":"Obesity and cancer mechanisms: cancer metabolism","volume":"34","author":"Hopkins","year":"2016","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1165510","article-title":"Development and validation of a new prognostic immune\u2013inflammatory\u2013nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03432-3","article-title":"The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model","volume":"22","author":"Ma","year":"2024","journal-title":"World J Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.2147\/jir.S468215","article-title":"Predictive efficacy of the advanced lung cancer inflammation index in hepatocellular carcinoma after hepatectomy","volume":"17","author":"Qiu","year":"2024","journal-title":"J Inflammation Research Volume"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-02972-4","article-title":"The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2023","journal-title":"World J Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/dcr.0000000000001658","article-title":"Advanced lung cancer inflammation index predicts outcomes of patients with colorectal cancer after surgical resection","volume":"63","author":"Kusunoki","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1047326","article-title":"The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ccell.2020.06.007","article-title":"IL6\/STAT3 signaling hijacks estrogen receptor \u03b1 Enhancers to drive breast cancer metastasis","volume":"38","author":"Siersb\u00e6k","year":"2020","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.09.002","article-title":"Metabolic crosstalk in the breast cancer microenvironment","volume":"121","author":"Dias","year":"2019","journal-title":"Eur J Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plipres.2017.11.002","article-title":"Adipocyte biology in breast cancer: From silent bystander to active facilitator","volume":"69","author":"Choi","year":"2018","journal-title":"Prog Lipid Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0812","article-title":"Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival","volume":"10","author":"Benoy","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1094823","article-title":"The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target","volume":"14","author":"Shibabaw","year":"2023","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19727-9","article-title":"Combined influence of nutritional and inflammatory status and breast cancer: findings from the NHANES","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Public Health"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08302-2","article-title":"Dynamic neutrophil-to-lymphocyte ratio: A novel prognosis measure for triple-negative breast cancer","volume":"27","author":"Moldoveanu","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:37:57Z","timestamp":1749015477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":56,"alternative-id":["10.3389\/fonc.2025.1598069"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1598069","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1598069"}}